Helix BioMedix, Inc. (HXBM)

Market Cap	1.24M +22.2%
Revenue (ttm)	2.07M +14.6%
Net Income	-2.58M
EPS	-15.59
Shares Out	224.71K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	350
Open	6.50
Previous Close	n/a
Day's Range	6.50 - 6.50
52-Week Range	1.00 - 6.50
Beta	1.73
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Helix BioMedix

Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: HXBM

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 8, 2026

Data Sources Report a data error